Article Details
Retrieved on: 2021-04-26 09:33:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here